Friday, October 30, 2020

Novartis expands Kymriah® manufacturing footprint with first-ever approved site for commercial ...

With active research underway to broaden the impact of cell and gene therapy in oncology, Novartis is going deeper in hematological malignancies, ...
http://dlvr.it/RkfBy1
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...